October 29, 2018 – ArchiMed’s new mid-market buy-and-build fund, MED Platform I, has received major commitments from European and North American institutional investors and family offices ...

Jeisys Medical was acquired by Archimed’s MED Platform II fund Jeisys Medical’s revenues increased 44 percent annually in the three years through fiscal 2023 Archimed is an investment firm ...

ArchiMed SAS, a France-based firm focused on European health-care deals, said it closed on more than half of the €800 million ($910.7 million) it is seeking for a new midmarket health-care fund. One ...

MIDDLETON, Wis., April 18, 2022 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ: NTUS), (the “Company” or “Natus”), a leading provider of medical device solutions to screen ...

European healthcare-focused private equity firm ArchiMed closed its second fund at its €315 million hard cap after a four-month fundraising campaign. Nearly 30 investors, mainly from the U.S. and ...

ArchiMed SAS, a France-based firm focused on European health-care deals, said it closed on more than half of the €800 million ($910.7 million) it is seeking for a new midmarket health-care fund.